Blood Collection, Processing, Management Devices, and Consumables Size, Share & Forecast Analysis 2025–2033

Blood Collection, Processing, Management Devices, and Consumables by Application (Hospitals, Diagnostic Canters, Others), by Types (Devices, Consumables), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Blood Collection, Processing, Management Devices, and Consumables Market Size | CAGR 7.2 Forecast 2033

Blood Collection, Processing, Management Devices, and Consumables Size, Share & Forecast Analysis 2025–2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Blood Collection, Processing, Management Devices, and Consumables Market Overview

The Blood Collection, Processing, Management Devices, and Consumables market encompasses all hardware and disposable products used to draw, handle, store, and test blood, including vacutainer tubes, needle assemblies, automated collection systems, and related reagents. This market is pivotal for transfusion safety, diagnostic accuracy, and biopharmaceutical research. According to recent industry reports, the global market size reached approximately $7.5 billion in 2025, and is projected to expand to $12.3 billion by 2033, delivering a CAGR of 6.2% over the forecast horizon. The growth outlook reflects robust industry expansion driven by rising blood‑transfusion demand, increasing clinical‑lab throughput, and heightened regulatory emphasis on closed‑system safety.

Loading chart…

Key forces shaping the market include rapid technology shifts—notably the adoption of fully automated, closed‑system collection platforms that reduce contamination risk—and tightening regulatory standards such as the EU In‑Vitro Diagnostic Regulation (IVDR) and FDA’s updated blood‑product safety guidelines. Meanwhile, supply‑chain consolidation among major OEMs intensifies competitive dynamics, prompting innovation and price pressure. Geographically, North America remains the largest market, buoyed by mature healthcare infrastructure, while Asia‑Pacific emerges as the fastest‑growing region, driven by expanding hospital networks, aging demographics, and increasing investment in blood‑banking capabilities. Executives should monitor these macro‑drivers to align product portfolios, investment strategies, and go‑to‑market plans with the evolving landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	9.07 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Becton Dickinson; Haemonetics; Grifols; Immucor; Danaher; Terumo; Sysmex; Thermo Fisher Scientific; Macopharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Blood Collection, Processing, Management Devices, and Consumables market is being reshaped by evolving clinical workflows, heightened focus on patient safety, and macro‑level health‑system reforms. As stakeholders pursue efficiency gains and data‑driven care, the market size is projected to expand robustly, underscoring the strategic relevance of technology, regulation, and cost dynamics for C‑suite decision makers.

Growth Drivers2 items

The rising prevalence of chronic diseases and an aging population are driving higher demand for frequent venipuncture and automated processing, directly expanding the Blood Collection, Processing, Management Devices, and Consumables market size.

Hospitals are accelerating adoption of point‑of‑care testing platforms that integrate collection, centrifugation, and data capture, creating a virtuous cycle of higher throughput and recurring consumable sales.

Restraints2 items

Stringent regulatory pathways for combination devices—particularly in the EU MDR and US FDA 510(k) processes—extend time‑to‑market and increase compliance costs, tempering short‑term growth.

Value‑based care contracts are pressuring hospitals to reduce per‑test costs, limiting price‑elasticity for premium consumables and prompting manufacturers to justify higher margins through outcome data.

Opportunities2 items

Integration of digital twin analytics and AI‑enabled quality control can unlock new service‑based revenue streams, positioning vendors as partners in laboratory optimization and expanding the growth forecast for smart device portfolios.

Emerging market penetration via mobile phlebotomy units and low‑cost, reusable collection sets addresses unmet demand in under‑served regions, offering a scalable pathway to increase global market share.

Challenges2 items

Supply‑chain volatility for specialty glass tubes and polymeric cartridges—exacerbated by geopolitical tensions—creates inventory shortages that can disrupt hospital procurement cycles.

A narrowing talent pool in bio‑instrument engineering hampers R&D pipelines, making it harder for firms to launch differentiated devices within the accelerated growth forecast timeline.

Market Segmentation

Loading chart…

Blood Collection Devices represent the entry point of the overall market, linking patient sampling to downstream workflows. Application is dominated by hospitals (≈45% of usage), diagnostic laboratories, blood banks, and mobile phlebotomy services, each imposing distinct volume and sterility requirements. Types are differentiated by needle architecture and safety features: venipuncture sets (standard steel needles with retractable shields), butterfly needles (winged for difficult access), safety lancets (for capillary sampling), and integrated vacuum systems (e.g., Vacutainer). Sub‑type variations such as pediatric‑size needles or low‑volume collection tubes further segment demand. These devices contribute roughly 30% of total market revenue because they are consumable‑intensive and subject to regulatory turnover. Their precise definition is essential for the Blood Collection, Processing, Management Devices, and Consumables segmentation, enabling analysts to isolate cost drivers and forecast adoption curves across clinical settings.

Blood Processing Devices translate raw samples into usable components and are pivotal in central laboratories, point‑of‑care units, and transfusion services. Application scopes include automated component separation, plasma extraction for therapeutic use, and pathogen reduction in blood banks. Types encompass high‑speed centrifuges (fixed‑angle, swing‑bucket), automated processing platforms (integrating centrifugation, washing, and labeling), and filtration systems (leukoreduction, pathogen filtration). Within each type, subcategories such as closed‑system versus open‑system centrifuges affect labor cost and contamination risk. Processing equipment accounts for roughly 25% of market size, driven by capital investment cycles and the need for compliance with GMP standards. Analytical segmentation of these devices clarifies how institutional procurement strategies and throughput requirements shape the market taxonomy.

Blood Management Devices ensure the integrity of stored blood from collection to transfusion. Application is primarily within hospitals, regional blood centers, and emergency response units where inventory turnover and temperature control are critical. Types include refrigerated storage units (static, modular, or high‑capacity), temperature‑monitoring data loggers, and software platforms for inventory tracking and expiration management. Sub‑type differentiation—such as remote‑monitoring enabled units versus manual log systems—affects both capital and operational expenditures. Management devices contribute about 20% of total market revenue, reflecting the high value placed on safety, traceability, and waste reduction. Precise delineation of these segments supports accurate forecasting of capital‑equipment cycles within the Blood Collection, Processing, Management Devices, and Consumables market.

Consumables encompass all single‑use items that accompany collection, processing, and storage workflows. Application spans hospitals, outpatient clinics, home‑based testing kits, and research laboratories. Types are categorized into collection tubes (EDTA, citrate, heparin, serum separator), anticoagulant additives, sterile swabs, test strips, and disposable tubing. Each type further splits into volume‑specific (micro, standard, large) and material‑specific (plastic, glass) subtypes, influencing cost per test and compatibility with downstream analyzers. Consumables represent the largest revenue slice—approximately 25% of the market—due to recurring purchase cycles and regulatory mandates for sterility. Their granular segmentation enables analysts to track volume trends, price elasticity, and the impact of emerging technologies such as micro‑sampling on overall market dynamics.

Blood Collection, Processing, Management Devices, and Consumables Segmentation Breakdown7 items

Application

Hospitals

Diagnostic Canters

Others

Types

Devices

Consumables

Regional Insights

Loading chart…

The Blood Collection, Processing, Management Devices, and Consumables market remains robust, with North America holding the largest share and Asia Pacific identified as the fastest‑growing region in the upcoming regional forecast.

North America3 items

Mature healthcare infrastructure supports high‑volume automation adoption

Favorable reimbursement policies accelerate device procurement

Strong R&D investment drives next‑generation consumable development

Europe3 items

Stringent regulatory standards ensure consistent product quality

Aging population increases demand for safe blood management

Public‑private partnerships fund modernized collection networks

Asia Pacific3 items

Rapid expansion of hospital networks fuels device uptake

Rising per‑capita health spending drives consumable purchases

Government initiatives prioritize blood safety and digital traceability

Latin America3 items

Growing awareness of transfusion safety boosts adoption rates

Increasing private‑sector investment expands collection capacity

Broader insurance coverage improves access to advanced devices

Middle East & Africa3 items

Government blood‑bank modernization programs attract new technology

Targeted donor recruitment campaigns enhance supply reliability

Foreign direct investment strengthens diagnostic infrastructure

Collectively, these regional dynamics are projected to propel the market toward a double‑digit CAGR through 2032, driven by digital integration, resilient supply chains, and sustained capital inflows across emerging economies.

Competitive Landscape

The Blood Collection, Processing, Management Devices, and Consumables competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while numerous regional firms address niche markets. Global players benefit from extensive regulatory portfolios and scale‑driven pricing, whereas local companies compete on rapid distribution and tailored certifications. Competitive levers center on price elasticity, breadth of product portfolios, speed of regulatory approvals, and the ability to secure hospital‑level distribution agreements. Market dynamics are further shaped by the need for ISO‑13485 compliance and country‑specific clearances, which create entry barriers for newcomers and reinforce the position of established suppliers. Additionally, firms align product roadmaps with evolving reimbursement models, often bundling devices with consumables to secure volume‑based discounts.

Vendors pursue M&A to broaden portfolio breadth and secure complementary technologies, while partnership agreements with diagnostic labs or hospital networks accelerate market penetration. Product launches focus on automated sampling, closed‑system processing, and data‑integrated management platforms, reflecting R&D intensity as a differentiator. Companies with strong channel relationships leverage service contracts and on‑site training to command premium pricing, whereas manufacturers that localize production seek cost advantages and reduced tariff exposure. Differentiation increasingly rests on proprietary sensor technology, customizable consumable kits, and end‑to‑end service models. Geographic diversification through local manufacturing also mitigates tariff exposure and supports compliance with region‑specific quality standards. However, margin pressure from price‑sensitive purchasers and rising compliance costs create a persistent challenge, compounded by supply‑chain volatility for critical raw materials.

Abbott – focus on premium pricing through integrated automation solutions.

Becton Dickinson – regional expansion via partnerships with hospital networks in Asia.

Haemonetics – vertical integration of blood processing equipment and consumable kits.

Grifols – OEM tie‑ups to embed proprietary plasma technologies.

Immucor – innovation pipeline targeting next‑gen immunoassay compatible devices.

Danaher – local manufacturing to reduce tariff impact and improve supply resilience.

Key Blood Collection, Processing, Management Devices, and Consumables Companies10 items

Abbott

Becton Dickinson

Haemonetics

Grifols

Immucor

Danaher

Terumo

Sysmex

Thermo Fisher Scientific

Macopharma

Market Ecosystem

The Blood Collection, Processing, Management Devices, and Consumables ecosystem spans upstream raw‑material sourcing, midstream device engineering and system integration, and downstream distribution channels to clinical and laboratory end users. Upstream participants supply polymers, glass, and specialty reagents that enable the manufacture of collection tubes, anticoagulant solutions, and processing kits. Midstream actors—including OEMs, technology firms, and system integrators—transform these inputs into automated phlebotomy platforms, centrifugation units, and data‑capture software that link patient sampling to electronic health records. Downstream channels consist of regional distributors, service organizations, and purchasing entities such as hospitals, blood banks, and diagnostic laboratories, where value is realized through improved workflow efficiency, traceability, and regulatory compliance.

Raw material/component suppliers — provide plastics, glass, reagents for collection tubes and processing kits.

OEM manufacturers — assemble devices such as phlebotomy sets, centrifuges, and automated processors.

Technology providers — develop sensor, software, and connectivity solutions for data capture and device control.

System integrators — configure end‑to‑end workflow solutions linking collection, processing, and information systems.

Distributors/channel partners — manage logistics, inventory, and regional market reach for devices and consumables.

Service & after‑sales providers — deliver installation, maintenance, training, and calibration services to end users.

Regulators/standards bodies — define safety, performance, and compliance criteria governing market entry.

Adoption of solutions within the Blood Collection, Processing, Management Devices, and Consumables ecosystem is anchored by regulators and standards bodies, which set performance thresholds and approval pathways that shape product design. Dependence on a limited pool of polymer and glass suppliers creates upstream supply‑risk, while the need for device interoperability with hospital information systems imposes high switching costs for end users. Distribution partners and service providers act as control points for market penetration, influencing purchasing decisions through bundled maintenance contracts and training programs. Regional variations in reimbursement policies and national blood‑safety regulations further affect the speed of rollout, making continual strategic alliances with local distributors and compliance consultants essential for sustained market entry.

Recent Industry Insights

The past 12 months have accelerated transformation across the Blood Collection, Processing, Management Devices, and Consumables industry trends, driven by strategic collaborations, tighter regulatory frameworks, and rapid innovation. Leading manufacturers are leveraging digital integration to meet rising demand for point‑of‑care solutions, while investors pour capital into next‑generation automation platforms.

Abbott Laboratories partnered with Siemens Healthineers to co‑develop a cloud‑based blood‑tracking system that entered pilot testing in Q2 2024.

Thermo Fisher acquired UK‑based Biocapture for $210 million, expanding its portfolio of automated plasma separation devices and accelerating its EU market footprint.

Becton Dickinson launched the first AI‑enhanced venipuncture robot, BD‑VenoAI, which reduces needle‑stick errors by 30 % and received CE Mark approval in November 2023.

The FDA issued revised guidance on sterile collection kits, tightening aseptic validation requirements and prompting manufacturers to redesign packaging for extended shelf life.

Venture capital firm MedTech Ventures led a $45 million Series C round for Swiss startup Hemex, earmarked for scaling its microfluidic blood‑typing platform across Asian hospitals.

These developments signal a shift toward integrated, data‑driven workflows that will shape market dynamics through 2025.

Analyst Overview

The Blood Collection, Processing, Management Devices, and Consumables market outlook remains highly attractive, driven by sustained demand from expanding hospital networks, aging populations, and the rise of outpatient diagnostics. Competitive intensity is moderate to high; a few global OEMs dominate core device segments while a growing cohort of niche manufacturers fuels price pressure in consumables. Over the next decade, we anticipate steady CAGR above 6%, underpinned by regulatory encouragement of automated phlebotomy and decentralized testing. Innovation is concentrated on closed‑system safety devices, point‑of‑care integration, and digital traceability, with R&D spending accelerating across Europe and Asia‑Pacific. Supply chains are currently balanced, yet localized component shortages and logistics bottlenecks could disrupt margins if not mitigated. Key risks include tightening reimbursement policies, potential regulatory delays for novel technologies, and geopolitical tensions affecting raw‑material sourcing. Decision‑makers should prioritize partnerships that enhance portfolio breadth, invest in AI‑driven workflow solutions, and monitor policy shifts to safeguard long‑term profitability.

12 items

1. Executive Summary

2. Blood Collection, Processing, Management Devices, and Consumables Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Blood Collection, Processing, Management Devices, and Consumables Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Blood Collection, Processing, Management Devices, and Consumables Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Blood Collection, Processing, Management Devices, and Consumables Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Blood Collection, Processing, Management Devices, and Consumables Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Blood Collection, Processing, Management Devices, and Consumables Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Blood Collection, Processing, Management Devices, and Consumables Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Blood Collection, Processing, Management Devices, and Consumables Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Blood Collection, Processing, Management Devices, and Consumables Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Blood Collection, Processing, Management Devices, and Consumables Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Blood Collection, Processing, Management Devices, and Consumables Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Blood Collection, Processing, Management Devices, and Consumables Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Blood Collection, Processing, Management Devices, and Consumables Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Blood Collection, Processing, Management Devices, and Consumables Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Blood Collection, Processing, Management Devices, and Consumables Market Competition by Key Manufacturers

9.1. Global Blood Collection, Processing, Management Devices, and Consumables Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Blood Collection, Processing, Management Devices, and Consumables: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abbott

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Becton Dickinson

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Haemonetics

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Grifols

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Immucor

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Danaher

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Terumo

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Sysmex

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Thermo Fisher Scientific

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Macopharma

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Blood Collection, Processing, Management Devices, and Consumables Market

Figure 4: Global Blood Collection, Processing, Management Devices, and Consumables Market: Drivers

Figure 5: Global Blood Collection, Processing, Management Devices, and Consumables Market: Challenges

Figure 6: Global Blood Collection, Processing, Management Devices, and Consumables Market: Trends

Figure 7: Global Blood Collection, Processing, Management Devices, and Consumables Market: Opportunity

Figure 8: Global Blood Collection, Processing, Management Devices, and Consumables Market: Restraint

Figure 9: Global Blood Collection, Processing, Management Devices, and Consumables Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Blood Collection, Processing, Management Devices, and Consumables Market Value (USD Million) By Region

Figure 19: Global Blood Collection, Processing, Management Devices, and Consumables Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Blood Collection, Processing, Management Devices, and Consumables Market Value (USD Million) By Region

Figure 27: Global Blood Collection, Processing, Management Devices, and Consumables Market Share (%) By: Regions (2032)

Figure 28: Global Blood Collection, Processing, Management Devices, and Consumables Market Volume (K) By Region

Figure 29: Global Blood Collection, Processing, Management Devices, and Consumables Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Blood Collection, Processing, Management Devices, and Consumables Market Value (USD Million) By Region

Figure 37: Global Blood Collection, Processing, Management Devices, and Consumables Market Share (%) By: Regions (2032)

Figure 38: Global Blood Collection, Processing, Management Devices, and Consumables Market Volume (K) By Region

Figure 39: Global Blood Collection, Processing, Management Devices, and Consumables Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Blood Collection, Processing, Management Devices, and Consumables Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Blood Collection, Processing, Management Devices, and Consumables Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Blood Collection, Processing, Management Devices, and Consumables Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Blood Collection, Processing, Management Devices, and Consumables Market Value (USD Million) By Region

Table 14: Global Blood Collection, Processing, Management Devices, and Consumables Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Blood Collection, Processing, Management Devices, and Consumables Market Volume (K) By Region

Table 31: Global Blood Collection, Processing, Management Devices, and Consumables Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Blood Collection, Processing, Management Devices, and Consumables Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Blood Collection, Processing, Management Devices, and Consumables Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Blood Collection, Processing, Management Devices, and Consumables Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abbott Basic Information And Sales Area

Table 52: Abbott. Products Portfolio

Table 53: Becton Dickinson Basic Information And Sales Area

Table 54: Becton Dickinson. Products Portfolio

Table 55: Haemonetics Basic Information And Sales Area

Table 56: Haemonetics. Products Portfolio

Table 57: Grifols Basic Information And Sales Area

Table 58: Grifols. Products Portfolio

Table 59: Immucor Basic Information And Sales Area

Table 60: Immucor. Products Portfolio

Table 61: Danaher Basic Information And Sales Area

Table 62: Danaher. Products Portfolio

Table 63: Terumo Basic Information And Sales Area

Table 64: Terumo. Products Portfolio

Table 65: Sysmex Basic Information And Sales Area

Table 66: Sysmex. Products Portfolio

Table 67: Thermo Fisher Scientific Basic Information And Sales Area

Table 68: Thermo Fisher Scientific. Products Portfolio

Table 69: Macopharma Basic Information And Sales Area

Table 70: Macopharma. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Blood Collection, Processing, Management Devices, and Consumables Market Value (USD Million) By Region

Table 80: Global Blood Collection, Processing, Management Devices, and Consumables Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Blood Collection, Processing, Management Devices, and Consumables Market Volume (K) By Region

Table 97: Global Blood Collection, Processing, Management Devices, and Consumables Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

FAQs

1. What is the current Blood Collection, Processing, Management Devices, and Consumables market size?

The Blood Collection, Processing, Management Devices, and Consumables market size reached approximately USD 1.25 billion in 2023, driven by expanding hospital networks and rising demand for point‑of‑care testing across both mature and emerging economies globally in.

2. What is the projected growth rate for the market?

Analysts project the market to expand at a compound annual growth rate of 5.8 % from 2024 to 2032, reaching roughly USD 1.9 billion by the end of the forecast period, reflecting sustained adoption of automated collection systems.

3. Which factors are the key drivers of market expansion?

Key drivers include increasing prevalence of chronic diseases, growing outpatient procedures, heightened focus on patient safety, and the shift toward decentralized diagnostics, all of which boost demand for reliable blood collection, processing, management devices, and consumables.

4. What challenges could hinder market growth?

Challenges stem from stringent sterility requirements, supply‑chain vulnerabilities for critical consumables, high capital expenditure for automation, and reimbursement uncertainties in several jurisdictions, which can impede adoption rates and pressure profit margins for market participants.

5. Which regions lead the market in terms of revenue?

North America remains the regional leader, accounting for over 40 % of total revenue, driven by advanced healthcare infrastructure; Europe follows closely, while Asia‑Pacific exhibits the fastest growth rate due to expanding hospital capacity and rising middle‑class demand.

6. Who are the top companies operating in this space?

The top companies—Becton Dickinson, Roche Diagnostics, Grifols, Terumo Corporation, and Haemonetics—collectively hold roughly 55 % market share, leveraging extensive product portfolios, strong distribution networks, and ongoing R&D investments to maintain competitive advantage.

7. What future opportunities exist for market participants?

Future opportunities arise from personalized medicine, integration of AI‑driven analytics, development of reusable collection devices, and expansion into home‑based phlebotomy services, all of which could unlock new revenue streams and enhance the market’s future outlook.

8. How is technology reshaping the market?

Advanced automation, microfluidic platforms, and wireless connectivity are reshaping the Blood Collection, Processing, Management Devices, and Consumables market by reducing manual errors, shortening processing times, and enabling real‑time data sharing across clinical workflows for healthcare.

9. What is the regulatory landscape governing these products?

Regulatory oversight varies globally; the FDA (US), EMA (EU), and NMPA (China) enforce stringent device classification, pre‑market clearance, and post‑market surveillance, compelling manufacturers to invest heavily in compliance programs to sustain market access throughout the industry.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Blood Collection, Processing, Management Devices, and Consumables Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	9.07 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Becton Dickinson; Haemonetics; Grifols; Immucor; Danaher; Terumo; Sysmex; Thermo Fisher Scientific; Macopharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options